This product can be used in ELISA, WB, IP.ĭetermined by its binding ability to human ACE2 in a functional ELISA. Immobilized SARS-CoV-2-S1-RBD (V367F) at 6 μg/mL can bind human ACE2, the EC50 is 55.67 ng/mL. The biological activity was determined by its binding ability in a functional ELISA. Recombinant Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Surface glycoprotein was expressed in Mammalian cell with a 10xHis-tag at the C-terminus. Post-translational Modification Research.Identification of Polysaccharides with Antioxidant Activity.Identification of Polysaccharides with Antibacterial Activity.Identification of Glycans with Antiviral Activity.Identification of Polysaccharides with Anticancer Activity.Cancer-associated Carbohydrate Identification.Glycopeptide-based Cancer Vaccine Development.High-throughput Glycan Screening Service.Glycoprotein Detection by Affinity-Based Procedures.Glycoprotein Detection by Staining Procedures.Glyco-engineered Plant-based Expression System.Glyco-engineered Pichia pastoris Expression System.Glyco-engineered Mammalian Cell Expression System.Sugar-assisted Ligation for Glycoprotein Synthesis.Staudinger Ligation for Glycoprotein Synthesis.Expressed Protein Ligation for Glycoprotein Synthesis.Native Chemical Ligation for Glycoprotein Synthesis.Glycoprotein Remodelling for Glycoprotein Synthesis.Technologies for Glyco-code Based Diagnostics.Cancer Specific Glycosyltransferase Gene Expression Profile.

Tumor-associated Glycan Detection Service.

319 aa meeting